Filana Therapeutics, Inc. (FLNA) Ownership
FLNA ownership summary
as of October 18, 2026- Institutions
- 26.8% of shares outstanding
- Insiders
- 2.05% of shares outstanding
- Shares outstanding
- 48.3M
- Float
- 46.9M shares available to trade
- Short interest
- 12.44% 5.9M shares short
- Days to cover
- 1.16 short interest down 5.3% vs prior month
- Institutions 26.81%
- Insiders 2.05%
- Other investors 71.14%
FLNA top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard Capital Management, LLC | 4.09% | 2.0M | $1.4M | +44,038 (+2.3%) | June 30, 2026 |
| 2 | Two Sigma Investments LLC | 3.54% | 1.7M | $1.2M | −277,456 (−14.0%) | June 30, 2026 |
| 3 | Marshall Wace Asset Management Ltd | 3.31% | 1.6M | $1.1M | −414,995 (−20.6%) | June 30, 2026 |
| 4 | BlackRock Inc | 3.01% | 1.5M | $1.0M | +39,047 (+2.8%) | June 30, 2026 |
| 5 | The Goldman Sachs Group Inc | 1.38% | 669K | $468,154 | +627,468 (+1,518.4%) | June 30, 2026 |
| 6 | Geode Capital Management, LLC | 1.27% | 616K | $430,857 | +19,268 (+3.2%) | June 30, 2026 |
| 7 | D. E. Shaw & Co LP | 1.00% | 485K | $339,518 | −74,180 (−13.3%) | June 30, 2026 |
| 8 | GMT Capital Corp | 0.93% | 450K | $315,070 | — | June 30, 2026 |
| 9 | Renaissance Technologies Corp | 0.81% | 390K | $272,721 | +62,842 (+19.2%) | June 30, 2026 |
| 10 | Squarepoint Ops LLC | 0.66% | 318K | $222,866 | +318,380 (0.0%) | June 30, 2026 |
| 11 | Vanguard Fiduciary Trust Co | 0.65% | 316K | $221,122 | +41,958 (+15.3%) | June 30, 2026 |
| 12 | Acadian Asset Management LLC | 0.61% | 295K | $206,541 | +10,846 (+3.8%) | June 30, 2026 |
| 13 | Susquehanna International Group, LLP | 0.60% | 292K | $204,412 | −155,261 (−34.7%) | June 30, 2026 |
| 14 | GSA Capital Partners LLP | 0.56% | 269K | $188,587 | +51,566 (+23.7%) | June 30, 2026 |
| 15 | Group One Trading, LLC | 0.51% | 244K | $170,806 | −58,616 (−19.4%) | June 30, 2026 |
| 16 | State Street Corp | 0.43% | 209K | $146,374 | −30,882 (−12.9%) | June 30, 2026 |
| 17 | Vanguard Portfolio Management, LLC | 0.27% | 133K | $92,818 | −96 (−0.1%) | June 30, 2026 |
| 18 | Connor Clark & Lunn Inv Mgmt Ltd | 0.27% | 132K | $92,609 | −4,633 (−3.4%) | June 30, 2026 |
| 19 | Federated Hermes Inc | 0.25% | 120K | $83,966 | +4,855 (+4.2%) | June 30, 2026 |
| 20 | Northern Trust Corp | 0.24% | 114K | $80,025 | −34,872 (−23.4%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 10 holders added 1.2M shares and 9 cut 1.1M.
FLNA top mutual fund and ETF holders
16 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 2.83% | 1.4M | $956,090 | — | August 31, 2026 |
| 2 | Fidelity Extended Market Index | 0.56% | 269K | $188,136 | +14,626 (+5.8%) | August 31, 2026 |
| 3 | iShares Micro-Cap ETF | 0.29% | 142K | $99,221 | −978 (−0.7%) | September 30, 2026 |
| 4 | Vanguard Health Care ETF | 0.28% | 134K | $93,927 | +576 (+0.4%) | August 31, 2026 |
| 5 | Fidelity Total Market Index | 0.17% | 81K | $57,023 | — | August 31, 2026 |
| 6 | Fidelity Series Total Market Index | 0.15% | 72K | $50,732 | — | August 31, 2026 |
| 7 | Nationwide Bailard Sm Cp Val M | 0.10% | 49K | $34,148 | +48,783 (0.0%) | August 31, 2026 |
| 8 | Goldman Sachs Absolute Ret Trckr Instl | 0.09% | 43K | $29,823 | +28,633 (+204.9%) | June 30, 2026 |
| 9 | Fidelity ZERO Total Market Index | 0.06% | 31K | $21,739 | — | August 31, 2026 |
| 10 | Fidelity ZERO Extended Market Index | 0.06% | 29K | $20,407 | +13,075 (+81.3%) | August 31, 2026 |
| 11 | Vanguard Balanced Index Inv | 0.05% | 22K | $15,581 | −2,266 (−9.2%) | August 31, 2026 |
| 12 | Vanguard U.S. Eq Idx £ Acc | 0.03% | 16K | $11,128 | — | August 31, 2026 |
| 13 | Fidelity Flex Small Cap Index | 0.02% | 10K | $7,034 | +2,593 (+34.8%) | July 31, 2026 |
| 14 | 1290 VT Micro Cap K | 0.02% | 10K | $7,013 | — | August 31, 2026 |
| 15 | Fidelity Nasdaq Composite Index | 0.02% | 9,088 | $6,362 | −30,865 (−77.3%) | August 31, 2026 |
| 16 | Fidelity VIP Extended Mkt Indx Initial | 0.01% | 3,495 | $2,446 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
FLNA insider transactions
latest 5| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2025-11-19 | Richard Barry | Buy | $2.75 | 73,385 | $201,809 |
| 2025-09-30 | Robert Christopher Cook | Buy | $2.91 | 13,725 | $39,940 |
| 2025-09-22 | Richard Barry | Buy | $2.28 | 7,172 | $16,352 |
| 2025-09-19 | Richard Barry | Buy | $2.29 | 47,308 | $108,335 |
| 2025-09-18 | Richard Barry | Buy | $2.24 | 190,633 | $427,018 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
FLNA shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns FLNA
Institutional investors own 26.8% of Filana Therapeutics's shares and insiders 2.05%. The largest holder is Vanguard Capital Management, LLC with 4.09% of the shares (2.0M), as of June 30, 2026. Among the top 20 institutions, 10 added shares and 9 reduced their stake in the latest filings. Short interest is 12.44% of the float, or 1.16 days of average trading volume. The share count rose 705.1% since 2014.
Related: FLNA analyst forecast, FLNA key metrics. See the FLNA stock overview for the latest quote and news.
FLNA ownership FAQ
Who owns the most Filana Therapeutics stock?
The largest shareholders of Filana Therapeutics are Vanguard Capital Management, LLC (4.09%), Two Sigma Investments LLC (3.54%), Marshall Wace Asset Management Ltd (3.31%), BlackRock Inc (3.01%), The Goldman Sachs Group Inc (1.38%).
What percentage of Filana Therapeutics is owned by institutions?
Institutions hold 26.8% of Filana Therapeutics's shares outstanding; insiders hold 2.05%.
Which funds own Filana Therapeutics?
The largest fund holders of Filana Therapeutics are Vanguard MStar Total Stk Mkt Idx Invest (2.83%), Fidelity Extended Market Index (0.56%), iShares Micro-Cap ETF (0.29%), Vanguard Health Care ETF (0.28%), Fidelity Total Market Index (0.17%).
What is Filana Therapeutics's short interest?
5.9M shares of Filana Therapeutics were sold short, 12.44% of the float; at the average daily volume it would take 1.16 days to cover.
Are insiders buying or selling Filana Therapeutics?
Of the latest 5 reported insider transactions in Filana Therapeutics (since September 18, 2025), 5 were purchases and 0 were sales.
How many shares of Filana Therapeutics are outstanding?
Filana Therapeutics has 48.3M shares outstanding, of which 46.9M are in the public float.